福安药业(300194.SZ)：吗啉硝唑收到化学原料药上市申请批准通知书

Core Viewpoint - Fuan Pharmaceutical's subsidiary, Ningbo Tianheng Pharmaceutical, has received approval from the National Medical Products Administration for the market launch of the chemical raw material drug, Morinazole, which is used to treat infections caused by anaerobic bacteria [1] Group 1 - Fuan Pharmaceutical's subsidiary, Tianheng Pharmaceutical, has been granted a marketing approval notice for Morinazole [1] - Morinazole is primarily used for treating infectious diseases caused by anaerobic bacteria, including lower respiratory tract infections, pelvic inflammatory disease, and sepsis [1]